A Prospective Randomized Study of Corticosteroids as Adjuvant Drugs to Opioids in Advanced Cancer Patients

Abstract

This randomized controlled study evaluated the role of corticosteroids as adjuvants to opioid therapy in 76 advanced cancer patients with pain who requiring strong opioids. Patients were divided in 2 groups. Group O received conventional opioid treatment. Group OS received dexamethasone (8 mg orally) along with conventional treatment. Pain and symptom intensity, sense of well-being, and opioid escalation index and distress score were recorded at weekly intervals until death. No differences in pain intensity, opioid consumption, and opioid escalation index were found in 66 patients who survived 33 to 37 days. Corticosteroids did not provide significant additional analgesia to opioids, but persistently decreased opioid-related gastrointestinal symptoms for the patients with limited survival and improved the sense of well-being for some weeks. Corticosteroidrelated toxicity was minimal. Further studies with an increased sample size are necessary to detect any minimal difference in analgesia between the two groups.

Keywords

cancer pain corticosteroids opioids adjuvant

Get full access to this article

View all access options for this article.

References

Twycross R . The risks and benefits of corticosteroids in advanced cancer. Drug Saf. 1994;11:163-178.

Gannon C , McNamara P . A retrospective observation of corticosteroid use at the end of life in a hospice. J Pain Symptom Manage. 2002;24:328-334.

Mercadante S , Fulfaro F , Casuccio A . Pattern of drug used by advanced cancer patients followed at home. J Palliat Care. 2001;17:37-40.

Lussier D , Portenoy RK . Adjuvant analgesics in pain management. In: Doyle D , Hanks G , Cherny NI , Calman K , eds. Oxford Textbook of Palliative Medicine. New York, NY: Oxford University Press; 2004:349-377.

Reeve AJ , Patel S , Fox A , Walker K , Urban L . Intrathecally administered endotoxin or cytokines produce allodynia, hyperlagesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain. 2000;4:247-257.

Watkins L , Maier S , Goehler L . Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995;63:289-302.

Vaccarino A , Couret L . Relationship between hypothalamicpituitary-adrenal activity and blockade of tolerance to morphine analgesia by pain: a strain comparison. Pain. 1995;63:385-389.

Brack A , Rittner H , Machelska H , et al. Control of inflammatory pain by cytokines-mediated recruitment of opioid containing polymorphonuclear cells. Pain. 2004; 112:229-238.

Lim G , Wang S , Zeng Q , Sung B , Mao J . Evidence for a long-term influence on morphine tolerance after previous morphine exposure: role of neuronal glucocorticoid receptors. Pain. 2005;14:81-92.

10.

Bruera E , Roca E , Cedaro L , et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep. 1985;69:751-754.

11.

Della Cuna GR , Pellegrini A , Piazzi M . Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients. A placebo-controlled multicenter study. Eur J Clin Oncol. 1989;25:1817-1821.

12.

Kloke M , Rapp M , Bosse B , Kloke O . Toxicity and/or insufficient analgesia by opioid therapy: risk factors and the impact of changing the opioid. A retrospective analysis of 273 patients observed at a single center. Support Care Cancer. 2000;8:479-486.

13.

Mercadante S , Fulfaro F , Casuccio A . The use of steroids in advanced cancer patients followed at home. Support Care Cancer. 2001;9:386-389.

14.

Bruera E , Kuehn N , Miller MJ , Selmser P , Macmillan K . The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6-9.

15.

Mercadante S. Dardanoni G , Salvaggio L , Armata MG , Agnello A. Monitoring of opioid therapy in advanced cancer pain patients. J Pain Symptom Manage. 1997;13:204-212.

16.

Mercadante S , Fulfaro F , Casuccio A , Agnello A , Barresi L . Investigation on an opioid response categorization in advanced cancer patients. J Pain Symptom Manage. 1999;18:347-352

17.

Watanabe S , Bruera E . Corticosteroids as adjuvant analgesics. J Pain Symptom Manage. 1994;9:442-445.

18.

Feuer DJ , Broadley KE . Systematic review and metanalysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Ann Oncol. 1999;10:1035-1041.

19.

Laval G , Girardier J , Lassauniere JM , Leduc B , Haond C , Schaerer R . The use of steroids in the management of inoperable intestinal obstrution in terminal cancer patients: do they remove the obstruction? Palliat Med. 2000;14:3-10.

20.

Ettinger AB , Portenoy RK . The use of corticosteroids in the treatment of symptom associated with cancer. J Pain Symptom Manage. 1988;3:99-103.

21.

Portenoy RK Adjuvant analgesic agents. Hemat/Oncol Clin North Am. 1996;10:103-119.